Get in touch: send your photos, videos, news & views by texting YORK to 80360 or send an email»
Tissue Regenix looks to launch wound-healing tissue production process
A YORK-based medical technology specialist has seen the first production of wound-healing tissue by its US partner as it looks to commercially launch the process.
Tissue Regenix, based at the Biocentre in Heslington, has been working with Community Tissue Services (CTS), one of the largest tissue banks in the US, to develop its DermaPure product by using technology designed in York to create skin tissue that can be applied to heal chronic wounds.
Since signing the processing agreement in June this year the firms have been working to transfer Tissue Regenix’s patented dCELL technology for use in the US market. They are now celebrating the first successful production of DermaPure.
Bosses at Tissue Regenix say they remain on course for commercial launch of DermaPure in the US during the first half of 2014.
Greg Bila, president of Tissue Regenix Wound Care Inc, said: “The US acute and chronic wound care market represents a major commercial opportunity for Tissue Regenix.
“This successful transfer of expertise to CTS is a significant step forward in our aim to enter this market.
“A lot has already been achieved with CTS in a relatively short amount of time, and this is because of both organisations’ clear commitment to developing transformational regenerative medical devices that could benefit patients.
“We look forward to making further progress with DermaPure as we aim to bring the product to the US market in the first half of 2014.”
Tissue Regenix’s DermaPure works by taking human donor skin and removing the DNA and cells, using the dCELL process to leave a natural biological scaffold that can be placed in the wound to aid natural healing by attracting the patient’s own cells to the wound area.
Currently 6.5 million patients in the US are afflicted with chronic wounds. The partnership with CTS is allowing Tissue Regenix to target the existing $1.4 billion market for wound healing devices and equipment, which is anticipated to reach $1.5 billion by 2016.
Comments are closed on this article.